BridgeBio Pharma, Inc. (BBIO) Dividend Analysis
This company discontinued its dividend after 2019.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
Last dividend was paid in 2019. The company has not paid dividends in the last 6 years.
Does BridgeBio Pharma (BBIO) pay a dividend?
BridgeBio Pharma (BBIO) stopped paying a dividend after 2019 and pays nothing today. It returns cash through buybacks instead, at roughly a 1.6% buyback yield over the last twelve months. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does BridgeBio Pharma (BBIO) pay a dividend?+
No. BridgeBio Pharma (BBIO) does not currently pay a dividend. The last payment in our data was in 2019, and nothing has been paid since.
How does BridgeBio Pharma return cash to shareholders?+
Through share buybacks rather than dividends. Over the last twelve months BridgeBio Pharma reduced its share count at a rate equivalent to a 1.6% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.
Could BridgeBio Pharma afford to pay a dividend?+
Not currently. BridgeBio Pharma's free cash flow is negative at -$435 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with BridgeBio Pharma.
SourceDividend analysis computed from the 10-Q filed 3 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 11 Aug 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Related stocks: Pharmaceutical Preparations
Spot a number that looks wrong?
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.